30 novembre 2018 | International,

Reinventing Drug Discovery and Development for Military Needs

Flying at 50,000 feet, diving deep in the ocean, or hiking for miles with gear through extreme climates, military service members face conditions that place unique burdens on their individual physiology. The potential exists to develop pharmacological interventions to help service members complete their toughest missions more safely and efficiently, and then recover more quickly and without adverse effects, but those interventions must work on complex physiological systems in the human body. They will not be realized under the prevailing system of drug discovery and development with its focus on engaging single molecular targets. DARPA created the Panacea program to pursue the means of rapidly discovering, designing, and validating new, multi-target drugs that work with the body’s complexity to better support the physiological resilience and recovery of military service members.

The premise of Panacea is that the physiological systems of the human body work in complex and highly integrated ways. Drugs exert effects on our bodies by physically interacting with and changing the functional state of biomolecules that govern the functions of cells and tissues. Most drugs target proteins, which are the principle cellular workhorses. Ideally, drugs would target multiple proteins simultaneously to exert precise, network-level effects.

One major problem facing the drug development community is that the functional proteome — the complete collection of proteins and their roles in signaling networks — is largely dark to science. Despite being able to identify many of the proteins within a cell, researchers do not have a firm grasp on everything those proteins do and how they interact to affect physiology.

Due to this sparsity of structural and functional knowledge, the state of the art in drug development — what Panacea seeks to transform — is to engage only a very small fraction of known protein targets to achieve an effect. In fact, today’s approach to drug design singles out individual proteins in certain cells. That hyper-specificity is an attempt to minimize the risk of side effects and speed time to market, but it also yields a thin stream of drugs, many of which have similar mechanisms and relatively muted effectiveness compared to what might be achieved using a multi-target, systems-based approach.

“The current roster of drugs approved by the U.S. Food and Drug Administration only targets about 549 proteins, yet the body can produce more than six million different protein variants,” said Tristan McClure-Begley, the Panacea program manager. “The opportunity space for pharmacological intervention is vast and effectively untapped, but to access it we need new technology for understanding and targeting the human functional proteome.”

Panacea will address the lack of functional knowledge about the proteome. DARPA’s call to the research community is to consider complex physiological conditions relevant to military service members — for instance, metabolic stress during extreme endurance missions or pain and inflammation after injury; investigate the molecular mechanisms underlying those conditions; identify multiple, key molecular targets involved; and develop novel medicinal chemistry approaches to synthesize interventions that modulate those targets. DARPA believes that multi-target drugs will deliver safer and more efficacious solutions to military requirements for readiness and recovery over state-of-the-art interventions.

“Many of the most successful drugs produced in the past were found rather than made, and we knew what they did long before we knew how they did it,” McClure-Begley said. “To deliver improved interventions, we need to get to a place where we can investigate all of the potential proteins at play for a given condition and then prioritize sets of protein targets and signaling networks to effectively modulate physiological systems, regardless of what prior knowledge exists about those targets.”

The Panacea program aims to generate initial proof of concept for this new direction in drug discovery and development. Research will primarily involve animal models, human cell derived organoids, and high-throughput cell culture models. However, to support eventual transition to humans, DARPA will work with federal agencies to develop a regulatory pathway for future medical use. By the end of the five-year program, DARPA will require teams to submit novel drug candidates to the U.S. Food and Drug Administration for review as an Investigational New Drug or for Compassionate Use.

DARPA will hold a Proposers Day on December 14, 2018, in Arlington, Virginia, to provide more information about Panacea and answer questions from potential proposers. For details of the event, including registration requirements, visit https://go.usa.gov/xP6hD.

A forthcoming Broad Agency Announcement will fully describe the program structure and objectives.

https://www.darpa.mil/news-events/2018-11-28

Sur le même sujet

  • Airbus Corporate Jets wins first A321LR order for two aircraft

    14 août 2020 | International, Aérospatial

    Airbus Corporate Jets wins first A321LR order for two aircraft

    August 14, 2020 - Airbus Corporate Jets (ACJ) has won the first A321LR order for two aircraft from Lufthansa Technik, highlighting the market appeal and versatility of the A320neo Family. The aircraft will be multi-role capable and can be equipped for various types of missions, such as troop transport, different MedEvac role setups (medical evacuation) and will be operated by the German Air Force (Luftwaffe). Lufthansa Technik has now placed a total order of five Airbus aircraft on behalf of the German Government: three ACJ350-900s and two A321LRs. The A321LRs will be able to fly up to 163 passengers, up to 6 intensive care patients and up to 12 medium care patients, depending on the installed configuration, with a maximum range of 4,200nm/7,800km or 9.5 flight hours. “We are thrilled Lufthansa Technik has become the launch customer for the ACJ long-range version of the world’s best-selling A321neo,” said Benoit Defforge, ACJ President. “The ACJ320 Family features the widest cabin of any single-aisle aircraft in the sky, providing the greatest passenger comfort and intercontinental range. Lufthansa Technik and the German Government have a long-standing relationship with Airbus and we are proud of this new milestone order with us.” The A321LR is a member of the A320neo Family with over 7,400 orders by more than 110 customers. It delivers 30 per cent fuel savings and nearly 50 per cent reduction in noise footprint compared to previous generation competitor aircraft. With a range of up to 4,000nm (7,400km), with 206 passengers, the A321LR is the unrivalled long-range route opener, featuring true transatlantic capability and premium wide-body comfort in a single-aisle aircraft cabin. Featuring the most spacious cabins of any business jet, while being similar in size to competing large-cabin aircraft, the ACJ320neo Family also delivers similar operating costs. The ACJ320neo Family can do this because its lower maintenance and training overheads – part of its airliner heritage – deliver a similar total cost when combined with fuel and navigation and landing charges. Some 12,000 Airbus aircraft are in service worldwide, supported by a globe-spanning network of spares and training centres, giving corporate jet customers unmatched support in the field. Airbus corporate jet customers also benefit from services tailored to their particular needs, such as the “one call handles all” corporate jet customer care centre (C4you), and customised maintenance programmes. Combined with the inherent reliability that comes from aircraft designed to fly many times a day, the ACJ320neo Family is both dependable and available when customers need it. Airbus corporate jets are part of the world’s most modern aircraft family, which delivers, as standard, features which either cost more, or are unavailable, in competitors. These features include the protection and simplicity of fly-by-wire controls, the benefits of Category 3B autoland, and time and cost-saving centralised maintenance on all systems. Around 200 Airbus corporate jets are in service on every continent, including Antarctica, highlighting their versatility in challenging environments. #ACJ #A321LR @LHTechnik Your Contact Heiko Stolzke External Communications - Airbus Commercial Aircraft +49 151 4615 0714 Send an email Stefan Schaffrath Head of External Communications - Airbus Commercial Aircraft +33 6 16 09 55 92 Send an email View source version on Airbus: https://www.airbus.com/newsroom/press-releases/en/2020/08/airbus-corporate-jets-wins-first-a321lr-order-for-two-aircraft.html

  • Intel joins DARPA in search of encryption 'holy grail' | ZDNet

    9 mars 2021 | International, C4ISR, Sécurité

    Intel joins DARPA in search of encryption 'holy grail' | ZDNet

    Chip giant will participate in DARPA's DPRIVE program that aims to develop an accelerator for fully homomorphic encryption.

  • Silent Falcon UAS Technologies Offer Mission Selectable Capabilities to Solar/Electric sUAS Aircraft

    15 février 2020 | International, Aérospatial

    Silent Falcon UAS Technologies Offer Mission Selectable Capabilities to Solar/Electric sUAS Aircraft

    Albuquerque, New Mexico (February 12, 2020): Silent Falcon UAS Technologies (SFUAS) is excited to announce new options for it solar-powered, electric driven Silent Falcon E1 sUAS aircraft. The new customer selectable options allow the drone to:  Extend flight time 10+ hours  Select launch and recovery options o Vertical Take Off and Landing (VTOL) o Conventional o Catapult launch with parachute recovery  BVLOS beyond 100 km Grant Bishop, SFUAS CEO, said of the new options “Our customers have different missions and CONOPS, and our 20lb payload capacity allows our platform to meet those unique missions and CONOPS easily. The E1 is simple to operate and the new suite of options expands the mission capability for our customers. Need multiple sensors? More range? Operate in a confined space? As one customer likes to say, ‘PPMC-Plug and Play Mission Capability.’” Bishop added, “Our new options allow the E1 to have Sensors on time, On target anywhere in the world. The E1 is the ‘go to’ sUAS aircraft for ISR: easy to operate, affordable, rugged, and adaptable.” Don’t have a flight department? SFUAS provides global full service ISR and analysis with our E1 fleet. Recently several cities have turned to manned aircraft surveillance for security as reported by CBS “60 minutes.” A much better alternative is Silent Falcon ISR services. We provide better coverage and lower costs. SFUAS ISR Services can fly longer with more coverage and a live feed to multiple users on the ground with no gas, no noise, and zero carbon emissions. It’s a better choice for cities that want safety, clean air and no fuel costs. The SFUAS ISR Services team recently provided 24/7 security for the Trinidad and Tobago Police Service (TTPS), helping them maintain safety and security during the Port of Spain Carnival, a massive multi day celebration. Over four days, Silent Falcon assisted the TTPS in: identifying and pinpointing criminal activity, traffic management, crowd control, and managing and directing police assets. The long-endurance and long-range were key for this mission as Silent Falcon was able to provide continuous information and city-wide situational awareness to TTPS operational command center. This allowed the TTPS to have enhanced visibility and access to otherwise hard to capture situations. All SFUAS equipment and parts are designed and built in Albuquerque, New Mexico with NO Chinese content. The full line of SFUAS products, services, and support is available via GSA Contract No. GS07F248BA. SFUAS provides full service to customers, including operators for the aircraft and a full turnkey collection of data analysis, report, and storage services. From a smooth flight to an easily readable data report, customers will find the effectiveness of the aircraft options paired with the professionalism of the SFUAS staff to be ideal for any UAS requirements. ABOUT Silent Falcon™ UAS TECHNOLOGIES Silent Falcon UAS Technologies manufactures patent pending, state-of-the-art small Unmanned Aircraft Systems and components and sensors for the security, military and commercial markets including oil and gas and pipeline inspections, power utility inspections, large scale agriculture, natural resource management, security/ISR, public safety, and mapping/surveying. Silent Falcon is the only solar electric UAS to provide long endurance and range, silent operations, and an open interface payload bay accommodating a wide- variety of payloads that are also quick and easy to change. The company is headquartered in Albuquerque, New Mexico. https://www.suasnews.com/2020/02/silent-falcon-uas-technologies-offer-mission-selectable-capabilities-to-solar-electric-suas-aircraft/

Toutes les nouvelles